hsa-miR-144

ncRNA information

ncRNA name

hsa-miR-144

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

LHX2

Cancer information

Cancer name

Cervical Cancer

Cancer site

Cervix Uteri

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-144 overcomes resistance to CDDP via promoting cell apoptosis and inhibiting invasion through targeting LHX2 in cervical cancer cells.

Tissue resource

Hela cell lines

Sila cell lines

Experiment

qRT-PCR,Western blot


Institute

the Cell Bank of Chinese Academy of Sciences

Country

China

Continent

Asia